Sign in

NCT05959226Not yet recruiting

Effect of Exercise and Enteral Nutrition on Survival

Effect of Exercise and Enteral Nutrition Intervention on Survival in Patients With Locally Advanced Gastric Cancer: a Prospective Multicenter Randomized Controlled Study

Source: ClinicalTrials.gov · Last updated 25 Jul 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The present clinical trial was designed to explore the effect of postoperative physical exercise combined with enteral nutritional supplement on 3-year disease-free survival in patients with advanced gastric cancer.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
960 (estimated)
First submitted
17 Jul 2023
Start date
1 Aug 2023
Primary completion date
1 Aug 2026
Lead sponsor
The First Hospital of Jilin University
NCT number
NCT05959226

What you commit to

  • Study type: Interventional
  • Planned participants: 960
  • From 1 Aug 2023 to the primary completion date, 1 Aug 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Organ transplantation requires immunosuppressive therapy
  • Serious uncontrolled recurrent infections or other serious uncontrolled concomitant diseases
  • The patient has complications of Grade III or above in Clavien Dindo classification or has been hospitalized for more than 14 days after surgery due to various reasons;
  • Received radiotherapy, chemotherapy, or other neoadjuvant treatment before surgery

Other illness

  • People with uncontrolled epilepsy, Central nervous system disease or mental disorders
  • Patients with other malignant diseases in the past five years, excluding cured skin cancer and cervical Carcinoma in situ
  • Clinically severe (i.e. active) heart disease, such as symptomatic coronary heart disease, New York Heart Association (NYHA) grade II or more severe congestive heart failure, or severe arrhythmia requiring medication intervention, or a history of myocardial infarction within the past 6 months
  • Have a history of cerebral infarction or cerebral hemorrhage in the past 6 months
  • Urgent surgery required due to tumor emergencies (bleeding, perforation, obstruction)

Other

  • Patients diagnosed with distant metastasis through abdominal lung CT/MRI or PET-CT
  • Pregnant or lactating women
  • Patients with combined limb disabilities or motor dysfunction;
  • Pulmonary function test FEV1\<expected value 50%

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.